Accès ouvert
2024
article
OpenAlex
Jessica S. Kleer, Lillemor Skattum, Denise Dubler, Ingeborg Fischer et autres
Deficiencies of the early complement components of the classical pathway (CP) are well-documented in association with systemic lupus erythematosus (SLE) or SLE-like syndromes and severe pyogenic infections. Among these, complete C1s deficiency has been reported in nine cases so far. Here, we …
ch, se
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Corinne Légeret, Alexander Kutz, Brunner Jessica, Esther Mundwiler et autres
BACKGROUND: Over the last decades, the prevalence of coeliac disease (CD), an autoimmune disorder, rose to 1-2%. Whether patients with CD have higher risk of developing other autoimmune disorders such as type 1 diabetes, Hashimoto thyroiditis, or Graves` disease remains unclear. AIM: …
ch, us
(code pays fourni par la source)
2021
conference-paper
OpenAlex
Eduardo Nava, Luca Bernasconi, Esther Mundwiler, Sandra Bigi
Background/Purpose: Pediatric anti-NMDA receptor encephalitis is a rare and life-threatening disease. Timely diagnosis and treatment initiation directly influences outcome. Therefore, a high level of suspicion—particularly in mild new focal neurological deficits—is of utmost importance to prevent neurological sequelae. Case Presentation: We report …
ch
(code pays fourni par la source)
2019
article
OpenAlex
Hansotto Reiber, David Zeman, Pavlína Kušnierová, Esther Mundwiler et autres
de, cz, ch
(code pays fourni par la source)
2019
article
OpenAlex
Luca Bernasconi, Esther Mundwiler, Stephan Regenass, Vincent Aubert et autres
Background The quantification of serum IgG4 is commonly performed during the diagnostic workup of IgG4-related diseases (IgG4-RD). According to recent literature, IgG4 values above 1.35 g/L are characteristic of IgG4-RD and support its diagnosis at initial presentation. The purpose of this study …
ch
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Tristan Struja, Rebecca Jutzi, Noemi Imahorn, Marina Kaeslin et autres
BACKGROUND: Early diagnosis and relapse prediction in Graves' disease influences treatment. We assessed the abilities of four TSH-receptor antibody tests [TRAb] and one cyclic adenosine monophosphate bioassay to predict relapse of Graves' disease. METHODS: Observational study investigating patients presenting with Graves' disease …
ch
(code pays fourni par la source)
2017
article
OpenAlex
Tristan Struja, Leonie Briner, Aline Meier, Alexander Kutz et autres
ch
(code pays fourni par la source)
2017
article
OpenAlex
Tristan Struja, Marina Kaeslin, Fabienne Boesiger, Rebecca Jutzi et autres
Context First-line treatment in Graves’ disease is often done with antithyroid agents (ATD), but relapse rates remain high making definite treatment necessary. Predictors for relapse risk help guiding initial treatment decisions. Objective We aimed to externally validate the prognostic accuracy of the …
ch
(code pays fourni par la source)